P
Pinakeen Patel
Researcher at Baylor University
Publications - 3
Citations - 717
Pinakeen Patel is an academic researcher from Baylor University. The author has contributed to research in topics: Gene & Proinflammatory cytokine. The author has an hindex of 3, co-authored 3 publications receiving 661 citations.
Papers
More filters
Journal ArticleDOI
A Modular Analysis Framework for Blood Genomics Studies: Application to Systemic Lupus Erythematosus
Damien Chaussabel,Charles T. Quinn,Jing Shen,Pinakeen Patel,Casey Glaser,Nicole Baldwin,Dorothee Stichweh,Derek Blankenship,Lei Li,Indira Munagala,Lynda Bennett,Florence Allantaz,Asuncion Mejias,Monica I. Ardura,Ellen Kaizer,Laurence Monnet,Windy Allman,Henry B. Randall,Diane Johnson,Aimee Lanier,Marilynn Punaro,Knut M. Wittkowski,Perrin C. White,Joseph W. Fay,Goran B. Klintmalm,Octavio Ramilo,A. Karolina Palucka,Jacques Banchereau,Virginia Pascual +28 more
TL;DR: This work designed a strategy for microarray analysis that is based on the identification of transcriptional modules formed by genes coordinately expressed in multiple disease data sets that provide a stable framework for the visualization and functional interpretation of microarray data.
Journal ArticleDOI
How the study of children with rheumatic diseases identified interferon-α and interleukin-1 as novel therapeutic targets
Virginia Pascual,Virginia Pascual,Florence Allantaz,Pinakeen Patel,A. Karolina Palucka,Damien Chaussabel,Jacques Banchereau +6 more
TL;DR: Two of the oldest cytokines, type I interferon (IFN) and interleukin 1 (IL‐1), are identified as important pathogenic players in systemic lupus erythematosus (SLE) and systemic onset juvenile arthritis (SoJIA), respectively.
Journal ArticleDOI
IFN Priming Is Necessary but Not Sufficient To Turn on a Migratory Dendritic Cell Program in Lupus Monocytes
Alicia Rodriguez-Pla,Pinakeen Patel,Holden T. Maecker,Jose Rossello-Urgell,Nicole Baldwin,Lynda Bennett,Victoria Cantrell,Jeanine Baisch,Marilynn Punaro,Marilynn Punaro,Alisa Gotte,Alisa Gotte,Lorien Nassi,Tracey Wright,Anna Karolina Palucka,Jacques Banchereau,Virginia Pascual,Virginia Pascual +17 more
TL;DR: SLE serum “primes” a subset of monocytes to readily (<24 h) respond to TLR agonists and acquire migratory DC properties, which might explain how microbial infections exacerbate lupus.